Skip to main content
. 2019 Mar 14;11:264–269. doi: 10.1016/j.dadm.2019.01.009

Table 1.

Biomarkers for MetS before/during/after intervention

Results Pre-intervention Mid-intervention Post-intervention Percent change
HOMA-IR (<1.0) 31.0 6.3 3.5 −88.8%
Tri/HDL ratio (<2.0) 4.9 3.3 2.2 −55.5%
WHtR (<0.5) 0.62 0.61 .58 −6.45%
Fasting insulin mU/L (3-5) 97.2 21.3 14.3 −85.3%
Fasting glucose mg/dL (70-90) 129 119 98 −24.0%
HgA1c (%) 7.8% (diabetic) 5.6% 5.5% (normal) −29.5%
Triglycerides mg/dL (<150) 137 96 83 −39.4%
HDL mg/dL (>50) 28 29 38 +35.7%
LDL mg/dL (<100) 74 65 61 −17.6%
VLDL mg/dL (9-13) 27.4 19.2 16.6 −39.4%
Weight 257.2 250.4 243.0 −5.5%
Body fat % (<30%) 39.8% 37.4% 36.8% −3%